FV
F2 Ventures
Venture CapitalActiveF2 Ventures is a healthcare investment platform focused on arbitrage opportunities across the biotech sector.
14
Investments
4
Exits
$150M
AUM
28.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for F2 Ventures.
Investment Thesis & Strategy
F2 Ventures invests in various stages of fintech companies, seeking arbitrage opportunities within the biotech sector.
Investment Activity
Deals per year over the last 5 years
1
20191
20202
20214
20222
2023Portfolio Companies
Selected investments from their portfolio of 14 companies
R
Rondo Therapeutics
Biotech · Series A, 2023
A
Alumis
Biotech · Series B, 2023
A
Apogee Therapeutics
Biotech · Series B, 2022
C
Carmot Therapeutics
Biotech · Series B, 2022
R
Rgenta Therapeutics
Biotech · Series A, 2022
A
Acelyrin
Biotech · Series B, 2022
R
Rani Therapeutics
Biotech · Series C+, 2021
V
Vera Therapeutics
Biotech · Series B, 2021
V
Ventyx Biosciences
Biotech · Series A, 2020
V
Verve Therapeutics
Biotech · Series B, 2019
Notable Exits
CompanyTypeYearValue / Acquirer
FireblocksAcquisition2024—
LightricksAcquisition2024—
LemonadeIPO2020$1.6B
WixIPO2013—
Frequently Asked Questions
F2 Ventures focuses on Series A, Series B, Series C+ stage investments.